Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Malaysia Bakal Hasilkan Vaksin Covid-19 Pertama Oleh Pakar Tempatan | Malaysia dijangka akan mengeluarkan Vaksin Covid-19 yang pertama serta ia dikatakan telah dibangunkan 100 peratus oleh pakar tempatan menerusi laporan Sinar Harian, baru-baru ini.

Malaysia Bakal Hasilkan Vaksin Covid-19 Pertama Oleh Pakar Tempatan

Menurut Timbalan Menteri Kesihatan II, Datuk Aaron Ago Dagang, penyelidikan vaksin itu dijalankan di Institut Penyelidikan Perubatan (IMR) membabitkan dua teknologi vaksin iaitu virus ternyahaktif (inactivated virus) dan jujukan genetik pengutus (mRNA).

Jelasnya lagi bahawa vaksin di IMR dibangunkan secara 100 peratus pakar tempatan iaitu penyelidik di IMR, Universiti Putra Malaysia (UPM) dan Institut Penyelidikan Veterinar (VRI).

Beliau menjawab soalan tersebut selepas menjawab pertanyaan Datuk Mohd Salim Sharif (BN-Jempol) yang meminta kementeriannya memaklumkan perkembangan semasa pembangunan vaksin Covid-19 pertama negara yang dimulakan sejak November tahun lepas.

Mengulas lanjut mengenai perkara ini, Aaron berkata bahawa status terkini pembangunan vaksin Covid-19 di IMR adalah vaksin virus ternyahaktif telah berada di tahap penyahaktifan virus dan vaksin mRNA sedang menjalani proses ‘in vitro transcription’.

Jelasnya lagi, penghasilan vaksin Covid-19 ini akan mengambil masa untuk mencapai tahap keselamatan dan keberkesanan melalui kajian klinikal fasa ketiga serta kelulusan Bahagian Regulatori Farmasi Negara (NPRA), sebelum vaksin tersebut dapat digunakan di negara ini.

Difahamkan bahawa penyelidikan vaksin ini merupakan bidang baharu yang diceburi dan boleh digunakan oleh rakyat selepas keputusan kajian praklinikal (haiwan) dan kajian klinikal (manusia) menunjukkan ia selamat dan berkesan.

Sumber: Sinar Harian

Share.

Leave A Reply